Aditya G. Shivane

ORCID: 0000-0003-2737-083X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Glioma Diagnosis and Treatment
  • Meningioma and schwannoma management
  • Neurofibromatosis and Schwannoma Cases
  • Hereditary Neurological Disorders
  • Peripheral Neuropathies and Disorders
  • Vascular Malformations Diagnosis and Treatment
  • Neuroscience and Neuropharmacology Research
  • Nerve injury and regeneration
  • Pituitary Gland Disorders and Treatments
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Axon Guidance and Neuronal Signaling
  • Multiple Sclerosis Research Studies
  • Cerebrovascular and genetic disorders
  • Prion Diseases and Protein Misfolding
  • Alcoholism and Thiamine Deficiency
  • Muscle Physiology and Disorders
  • Ocular Oncology and Treatments
  • Inflammatory Myopathies and Dermatomyositis
  • Hippo pathway signaling and YAP/TAZ
  • Neurogenesis and neuroplasticity mechanisms
  • Skin and Cellular Biology Research
  • Neurological diseases and metabolism
  • Autopsy Techniques and Outcomes
  • Immunotoxicology and immune responses
  • Diet and metabolism studies

Derriford Hospital
2012-2023

University Hospitals Plymouth NHS Trust
2013-2022

National Health Service
2021

Plymouth Hospital
2014-2017

Peninsula College of Medicine and Dentistry
2013-2015

Leeds General Infirmary
2006-2013

Torbay Hospital
2012

Leeds Teaching Hospitals NHS Trust
2008

Loss of the Merlin tumor suppressor and activation Hippo signaling pathway play major roles in control cell proliferation tumorigenesis. We have identified completely novel for effector Yes-associated protein (YAP) Schwann (SC) plasticity peripheral nerve repair after injury. Injury to nervous system (PNS) causes a dramatic shift SC molecular phenotype generation repair-competent SCs, which direct functional repair. find that loss these cells catastrophic failure axonal regeneration...

10.1083/jcb.201606052 article EN cc-by-nc-sa The Journal of Cell Biology 2017-01-30

Schwannoma tumours typically arise on the eighth cranial nerve and are mostly caused by loss of tumour suppressor Merlin (NF2). There no approved chemotherapies for these surgical removal carries a high risk damage to or other close tissue. New treatments schwannoma NF2-null such as meningioma urgently required. Using combination human primary cells mouse models schwannoma, we have examined role Hippo signalling pathway in driving cell growth. both genetic ablation effectors YAP TAZ well...

10.1093/brain/awac342 article EN cc-by-nc Brain 2022-09-21

Genetic factors have been suggested to be involved in the pathogenesis of sporadic inclusion body myositis (sIBM). Sequestosome 1 (SQSTM1) and valosin-containing protein (VCP) are 2 key genes associated with several neurodegenerative disorders but yet thoroughly investigated sIBM. A candidate gene analysis was conducted using whole-exome sequencing data from 181 sIBM patients, whole-transcriptome expression performed patients genetic variants interest. We identified 6 rare missense SQSTM1...

10.1016/j.neurobiolaging.2016.07.024 article EN cc-by Neurobiology of Aging 2016-08-08

A minority of meningiomas are difficult to treat with surgery or radiotherapy, and chemotherapeutic alternatives limited. This study aims better understand pathways that active in meningiomas, order direct future treatment strategies. We investigated the expression activation multiple growth factor receptors, their ligands downstream signalling 30 using immunohistochemistry. Expression was correlated chromosome 22q loss. Membrane VEGF receptor (VEGFR) platelet-derived (PDGFR)β seen 83%...

10.1111/neup.12266 article EN Neuropathology 2015-11-10

Background: Successful treatment of glioblastoma (GBM) remains futile despite decades intense research. GBM is similar to most other malignant cancers in requiring glucose and glutamine for growth, regardless histological or genetic heterogeneity. Ketogenic metabolic therapy (KMT) a non-toxic nutritional intervention cancer management. We report the case 32-year-old man who presented 2014 with seizures right frontal lobe tumor on MRI. The cells were immunoreactive antibodies IDH1 (R132H)...

10.3389/fnut.2021.682243 article EN cc-by Frontiers in Nutrition 2021-05-31

Loss of the Merlin tumour suppressor causes abnormal de-differentiation and proliferation Schwann cells formation schwannoma tumours in patients with neurofibromatosis type 2. Within mature peripheral nerve normal development, differentiation maintenance myelinating non-myelinating is regulated by a network transcription factors that include SOX10, OCT6 (now known as POU3F1), NFATC4 KROX20 (also Egr2). We have examined for first time how their regulation cell development disrupted primary...

10.1093/brain/aws353 article EN cc-by-nc Brain 2013-02-01

Background/Aims: To evaluate the need for routine histopathological analysis of enucleated/eviscerated eyes and changes in indications eye removal. Methods: Retrospective review all enucleation/evisceration histopathology reports over 20 years. Clinical history was correlated with pathological findings. Two 10 year periods (1984–93, 1994–2003) were compared to detect Results: In total, 285 results traced from 1984 2003; 161 124 evisceration enucleation specimens, respectively. Glaucoma,...

10.1136/jcp.2005.029744 article EN Journal of Clinical Pathology 2006-01-27

Purpose. To know the occurrence and distribution of Pilomyxoid Astrocytomas amongst tumours previously diagnosed histologically as Pilocytic Astrocytoma to assess clinical impact this new entity. Methods. Retrospective Diagnostic review all cases WHO Grade I at a single Neurosurgical unit between 1990 2003. Results. Of total 91 identified, 9 were found have histology. these, 8 children (mean age 3.33 years) 1 adult. 6 hypothalamochiasmatic in location. The course was aggressive marked by...

10.3109/02688697.2012.752430 article EN British Journal of Neurosurgery 2013-01-03

Schwann cells myelinate axons of the peripheral nervous system. This process myelination is regulated by various transcription factors. c-Jun and Sox-2 are negative regulators control cell differentiation plasticity. Schwannoma within tumours no longer express myelin markers, show increased proliferation decreased apoptosis. We have shown previously that several signalling pathways activated in schwannoma situ, particular N-terminal kinase (JNK) pathway. Both vitro vivo we demonstrated...

10.1111/his.12062 article EN Histopathology 2012-11-07

10.1016/j.cdip.2007.04.003 article EN Current Diagnostic Pathology 2007-06-01

10.1016/j.mpdhp.2016.08.004 article EN Diagnostic histopathology 2016-08-31

We report a case of EBV+ and HHV-8+ multicentric Castleman disease with plasmablastic aggregates in an HIV-positive individual. A 41-year-old man presented early 2015 fevers, sweats, weight loss, intractable itching, on subsequent testing was found to be HIV positive. Investigations showed cervical lymphadenopathy splenomegaly. He treated for his symptoms resolved. His recurred January 2016, provisional diagnosis entertained. The HHV-8 (human herpesvirus-8) EBV (Epstein-Barr virus) viral...

10.1177/1066896917745584 article EN International Journal of Surgical Pathology 2017-12-03

"Thoraco-lumbar spontaneous ligamentum flavum haematoma." British Journal of Neurosurgery, 27(4), pp. 543–544

10.3109/02688697.2013.771144 article EN British Journal of Neurosurgery 2013-05-29
Coming Soon ...